Submitted January 29, 2007
Accepted May 16, 2007
ATF2 impairs glucocorticoid receptor-mediated
transactivation in human CD8+ T cells
Ling-bo Li, Donald Y.M. Leung, Matthew J Strand, and Elena Goleva*
Division of Pediatric Allergy & Immunology, National Jewish Medical and Research Center, Denver, CO, United States
Dept of Pediatrics, University of Colorado at Denver and Health Sciences Center, Denver, CO, United States
Div of Biostatistics, Nat'l Jewish Medical & Research Center, & Section of Biostatistics & Informatics, University of Colorado at Denver & Health Sciences Center, Denver, CO
* Corresponding author; email: golevae{at}njc.org.
Chronic inflammatory diseases often have residual CD8+ T cell infiltration despite treatment with systemic corticosteroids suggesting divergent steroid responses between CD4+ vs. CD8+ cells. To examine steroid sensitivity, dexamethasone (DEX)-induced histone H4 lysine (K)5 acetylation and glucocorticoid receptor (GCR)
translocation were evaluated. DEX treatment for 6h significantly induced H4 K5 acetylation in normal CD4+ cells (p=0.001), but not in CD8+ cells. DEX responses were functionally impaired in CD8+ as compared to CD4+ cells, using MKP-1 (1h) (p=0.02) and IL-10 mRNA (24h) (p=0.004) induction as a read-out of steroid-induced transactivation. Normal DEX-induced GCR
nuclear translocation and no significant difference in GCR
and GCR
mRNA expression were observed in both T cell types. Also, no significant difference in SRC-1, p300 and TIP60 expression was found. However, ATF2 expression was significantly lower in CD8+ compared to CD4+ cells (p=0.009). Importantly, inhibition of ATF2 expression by siRNA in CD4+ cells resulted in inhibition of DEX-induced transactivation in CD4+ cells. The data indicates refractory steroid-induced transactivation but similar steroid-induced transrepression of CD8+ cells as compared to CD4+ cells due to decreased levels of the histone acetyltransferase ATF2.